📰 Small Molecules News
Page 21 - Small Molecules News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Small Molecules. Real-time updates on events, politics, business and more.
April 4, 2022
Lonza Group (OTCMKTS:LZAGY – Get Rating) had its price objective lowered by analysts at Morgan Stanley from CHF 800 to CHF 785 in a research report issued on Monday, The Fly reports. The brokerage presently has an “equal weight” rating on the stock. A number of other brokerages have also commented on LZAGY. Stifel Nicolaus […]
April 2, 2022
Zacks Investment Research lowered shares of Lonza Group (OTCMKTS:LZAGY – Get Rating) from a hold rating to a sell rating in a report released on Wednesday morning, Zacks.com reports. According to Zacks, “Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life […]
April 2, 2022
Pune, India, April 02, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North Ameri
April 2, 2022
The significant players operating in the global automated and closed cell therapy processing system market Cellares Inc., Lonza, Cytiva, Terumo...
March 22, 2022
CHICAGO, March 22, 2022 /PRNewswire/ -- According to the new market research report "Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic
March 22, 2022
/PRNewswire/ -- According to the new market research report "Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab,...
March 6, 2022
Blueprint Medicines will dole out as much as $652 million to advance up to two protein degraders from Proteovant Therapeutics for oncology and hematology.
February 16, 2022
Merck has wandered off the beaten path to find a partner that can help it discover small molecule drug candidates against tough oncology and neurology targets.
February 9, 2022
In this product brochure, explore how the Creoptix WAVEsystem can detect and quantify biological interactions in real-time for high-quality kinetic data across a broad range of samples.
February 9, 2022
The accurate and efficient measurement of intermolecular interactions and binding events is a critical element for all manner of basic research and drug discovery programs. In this whitepaper, Creoptix highlights the features and benefits of using the waveRAPID method for fast and efficient kinetic characterization.